Evommune
Financing Rounds
- Series A
- Series B
- Series C
Round Led or Co-led By SymBiosis
Round Led or Co-led By SymBiosis
Round Led or Co-led By SymBiosis
Developer of a tissue-based approach designed to advance insights for inflammatory diseases. Evommune develops transformative medicines to advance insights and accelerate the development of medicines. The company has built a robust pipeline of unique therapies with the potential to help patients with chronic inflammatory diseases.
View Website
Modality
- Small Molecule
Indications
- Dermatology
- Immunology & Inflammation
Development Status
- Phase 1